• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SUN Limin,ZENG Kun,ZHANG Zhen,MU Yuejing,ZHAO Zhenzhen,HAN Ying.Exploration of "Three-in-One" collaborative inspection model for pharmaceuticals[J].Journal Of Pharmaceutical Research,2026,45(6):716-720[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 1131times   Download 574次 QR Code for this article
Scan with your phone!
药品“三合一”协同检查模式的探索
孙利民,曾琨,张镇,牟玥静,赵震震,韩莹
Font:Larger+|Default|Smaller-
(山东省食品药品审评查验中心,山东 济南 250014)
摘要:
目的 探索药品监管协同检查新模式,提升监管效能、优化检查资源配置、减轻企业负担,为完善药品监管体系、推动医药产业高质量发展提供实践参考。方法 回顾2023 年2月以来山东省在药品上市后变更备案领域推行 “三合一”检查的实践历程,以检查资源优化成效、检查员队伍能力提升为核心评价指标,系统总结该模式在机制构建、流程创新及队伍建设等方面的实施经验。结果与结论 通过制度完善、流程优化及全流程风险管控等关键举措,“三合一” 检查模式有效提升了检查资源配置效率,显著增强了检查员队伍综合能力,为药品监管协同化发展提供了可复制的实践路径,对提升药品监管质效、赋能产业高质量发展具有重要实践价值。
关键词:  药品监管  协同检查  监管效能
DOI:10.13506/j.cnki.jpr.2026.06.017
基金项目:
Received Date:October 24, 2025   Revision Date:January 28, 2026  
Exploration of "Three-in-One" collaborative inspection model for pharmaceuticals
SUN Limin,ZENG Kun,ZHANG Zhen,MU Yuejing,ZHAO Zhenzhen,HAN Ying
(Shandong Center for Food and Drug Evaluation & Inspection,Jinan 250014,China)
Abstract:
Objective To explore a novel model for collaborative drug regulatory inspections, with the aim of enhancing regulatory efficiency, optimizing the allocation of inspection resources, alleviating the burden on enterprises, and providing practical references for improving the drug regulatory system and promoting high-quality development of the pharmaceutical industry.Methods This study reviews the practical implementation of the "tripartite integrated inspection" model in the field of post-approval change filings in Shandong Province since February 2023. Focusing on the optimization of inspection resources and the enhancement of inspector competencies as core evaluation indicators, it systematically summarizes the implementation experience of this model in terms of mechanism establishment, process innovation, and team development.Results and Conclusion Through key measures such as institutional refinement, process optimization, and comprehensive risk management throughout the inspection cycle, the "tripartite integrated inspection" model has effectively improved the efficiency of inspection resource allocation and significantly strengthened the comprehensive capabilities of the inspection team. This model provides a replicable practical pathway for the collaborative development of drug regulation and holds significant practical value for enhancing the quality and effectiveness of drug oversight and empowering the high-quality development of the industry.
Key words:  Drug regulation  Collaborative inspection  Regulatory efficiency
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.